Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Debt Ratio data on file, last reported at 0.35 in Q4 2025.

• In Q4 2025, Debt Ratio fell 7.56% year-over-year to 0.35; the TTM figure through Dec 2024 stood at 0.38 (up 1565.86% YoY), while the FY2025 annual figure was 0.35, down 7.56% from the prior year.
• Debt Ratio retreated to 0.35 in Q4 2025, from 0.38 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.38 in Q4 2024 and bottomed at 0.02 in Q4 2023.
• A 3-year average of 0.25 and a median of 0.35 in 2025 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2024 — Debt Ratio soared 1565.86% — and 2025, when it dropped 7.56%.
• Year by year, Debt Ratio stood at 0.02 in 2023, then jumped by 1565.86% to 0.38 in 2024, then fell by 7.56% to 0.35 in 2025.
• The last three Debt Ratio figures came in at 0.35 (Q4 2025), 0.38 (Q4 2024), and 0.02 (Q4 2023), per Business Quant data.

Peer Comparison